Total cholesterol, lipoprotein, and triglyceride levels in tumor necrosis factor inhibitor-treated patients with psoriasis, psoriatic arthritis, or rheumatoid arthritis

Association between tumor necrosis factor inhibitor (TNFi) therapy and changes in C-reactive protein (CRP), blood pressure, and alanine aminotransferase (ALT) among patients with psoriasis, psoriatic arthritis, or rheumatoid arthritis

(2015) Jashin J. Wu et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study

(2013) O. Ahlehoff et al.   JOURNAL OF INTERNAL MEDICINE

Association Between Tumor Necrosis Factor Inhibitor Therapy and Myocardial Infarction Risk in Patients With Psoriasis

(2012) Jashin J. Wu et al.   ARCHIVES OF DERMATOLOGY

The Association of Psoriasis and Elevated Blood Lipids in Overweight and Obese Children

(2011) Corinna Koebnick et al.   JOURNAL OF PEDIATRICS

Effects of tumor necrosis factor-α blockade on metabolic syndrome components in psoriasis and psoriatic arthritis and additional lessons learned from rheumatoid arthritis

(2009) Jennifer Channual et al.   Dermatologic Therapy

High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: A population-based cohort study

(2008) Hilal Maradit Kremers et al.   ARTHRITIS AND RHEUMATISM